Assuming that Moderna does win regulatory clearance for mRNA-1273, the company stands to rake in a lot of money. It's lined up an agreement with the U.S. government to supply 100 million doses of the vaccine for $1.525 billion. That deal also includes an option to supply another 400 million doses of mRNA-1273. In addition, Moderna has either finalized or is in the process of finalizing supply agreements with the European Commission, Canada, and Japan.